In this article, we will take a detailed look at the 10 Trending Stocks Moving These Days.
Mohamed El-Erian, Allianz chief economic advisor, said in a recent interview on CNBC that we are in a “rational” AI bubble because the “promise” of the technology is huge. However, the analyst believes there would be just a few winners in the AI boom and many investments will result in “tears.”
“If we didn’t have AI, we wouldn’t look as good as we we do now when we we wouldn’t be outperforming the rest of the world. But we do have AI. So I’m not too worried that it’s an AI-driven boom. What I would stress is this is a rational bubble that a lot of money is being thrown at different AI actors at the micro level because the promise is so huge. That is a good thing. That’s what distinguish us from the rest of the world because different AI companies are competing and excelling. However, at the end of the day, they’re going to be just a few winners, a handful of winners, and therefore some of the investment will result in tears. But overall for the economy, this is good news. It promises significant productivity gains.”
El-Erian said that gold rose because investors around the world are moving away from the dollar. He believes banks and institutional investors are slowly buying gold to cut their exposure to the dollar, which has caused a spike in the precious metal’s prices.
READ ALSO: 7 Best Stocks to Buy For Long-Term and 8 Cheap Jim Cramer Stocks to Invest In.

Photo by Adam Nowakowski on Unsplash
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
10. The Roundhill Meme Stock ETF (NYSEArca:MEME)
Number of Hedge Fund Investors: N/A
Earlier in October, Scott Ladner, Chief Investment Officer at Horizon Investments, talked on CNBC about the launch of the new MEME ETF and said that he’s seeing 2021-like behavior in the market where retail investors were getting excited about meme stocks. However, the investor at the time warned that it’s probably “not going to end great” for meme stock investors.
It’s doing exactly what it’s supposed to do, frankly, but it is sort of endemic to what we are seeing retail folks do right now. If you look at just individual option trading or individual stock trading for the retail side, which makes up almost half the trading volume nowadays, it is well skewed towards buying calls, buying upside calls, essentially doing the types of things that we saw in 2021, as the meme stuff really ended up taking off. It’s that kind of behavior that we’re seeing again. And yeah, it’s probably not going to end great for some of that stuff, but for right now, it is at least somewhat supported largely by some of these fundamentals.
9. Shake Shack Inc (NYSE:SHAK)
Number of Hedge Fund Investors: 34
Josh Brown recently commented on JPMorgan adding fast casual dining chain Shake Shack Inc (NYSE:SHAK) to its top short ideas list. The analyst disagreed with the call and said he’s been a long-term investor in the stock:
“I’m in the name for almost 11 years since they came public. I’d point out what they’re saying is actually true. The consumer is being pressured right now. And you’re not just seeing that at Shake Shack—Cava is struggling, Sweetgreen is struggling, Chipotle looks terrible. So, this is a sector-wide phenomenon. This type of thing does come and go if you’re a long-term investor in the QSR space or the premium casual, whatever they call it these days. This is just something that you’re going to live through. What happens, though, is that eventually they price too much of that in, and then these companies start to surprise to the upside.”
The other questions they’re raising are about Shake Shack Inc (NYSE:SHAK) expansion plans. The new CEO wants to go to 1,500 units. There’s some questions about whether or not that will lead to cannibalization, which I think is absurd given the size of the world. I think 1,500 Shacks will be okay. So, I don’t disagree short-term that there is consumer spending concern. I do disagree with the idea of getting short a stock that’s already in a 30% drawdown, where enough people already are worried about it that they could have upside.”
Madison Small Cap Fund stated the following regarding Shake Shack Inc. (NYSE:SHAK) in its second quarter 2025 investor letter:
“Although Consumer Staples were challenged, our Consumer Discretionary investments stood out in terms of positive performance. Although tariff fears initially hurt some of our discretionary stocks, especially those with global supply chains, our best performing stock in aggregate was Shake Shack Inc. (NYSE:SHAK). SHAK’s Q1 results outpaced restaurant giants Chipotle (CMG) and McDonalds (MCD). Recent menu innovations, marketing investments, and operating initiatives are driving greater returns on investments, and the company has a long runway to grow units and compound those returns. Even though we’ve taken some profits, we consider this a core investment position and are excited about the long term prospects for the shares.”
8. Novo Nordisk A/S (NYSE:NVO)
Number of Hedge Fund Investors: 45
Karen Finerman, CEO & Co-founder, Metropolitan Capital Advisors, said in a recent program on CNBC that she likes NVO amid the company’s weight-loss drug business.
“All this talk about GLP-1s? No, I’m not going toward Lilly, which I do own, but I am also going toward Novo Nordisk A/S (NYSE:NVO).”
Vltava Fund stated the following regarding Novo Nordisk A/S (NYSE:NVO) in its third quarter 2025 investor letter:
“Novo Nordisk A/S (NYSE:NVO) probably needs no long introduction. It is one of Europe’s largest companies and a global leader in the treatment of two major lifestyle diseases – diabetes and obesity. The company has grown historically through the development and production of insulin and has held a dominant share of the global market in that group of products for decades. In recent years, obesity treatment has become its key growth segment. Its best-known product is Wegovy, which has proven to be highly effective in weight reduction. A smaller part of the business consists of drugs for rare diseases, particularly in the areas of hemophilia and growth hormone therapy. Novo Nordisk has highly integrated production, from molecule development to fully automated filling lines for injection pens, and global distribution to more than 170 countries, with a focus on the United States, Europe, and a rapidly growing share in Asia. Its biggest competitor is Eli Lilly, and these two companies now effectively form a duopoly in modern treatment of diabetes and obesity. Barriers to entry into the industry are extremely high, due to long development times, regulation, and enormous investments in production and distribution.
We have been following Novo Nordisk through the entire existence of the Vltava Fund, which means for more than 21 years. We have never owned its shares, however, either because we found them too expensive or had other more attractive opportunities available to us. During 2023–2024, Novo Nordisk definitively joined the ranks of global leaders in a new era of medicine. The success of its Ozempic and Wegovy medications has shown that obesity treatment is not just a niche segment, but a huge growth opportunity with direct impact on the health of millions of people. Demand for these drugs far exceeded supply, and the company invested heavily in expanding production. The market began to appreciate that Novo Nordisk had moved beyond traditional diabetology and become synonymous with innovation and long-term growth in an additional market segment. This narrative was increasingly reflected in the share price. From DKK 400 in the autumn of 2022, the price gradually climbed to beyond DKK 1,000 in the summer of 2024, at which time the stock was trading at roughly 45 times this year’s expected earnings. This price implicitly included very optimistic assumptions about future profitability…” (Click here to read the full text)
7. Intel Corp (NASDAQ:INTC)
Number of Hedge Fund Investors: 82
Ben Reitzes, Melius Research’s head of technology research, said in a recent program on CNBC that while he likes Intel’s leadership, he cannot recommend the stock. Here is what the analyst said:
“Lip-Bu Tan—we’re big fans. We’ve known him before, and he’s somebody people like and people want to work with. Give him a chance. There’s some speculation around him even working with AMD because we know he’s tight with Lisa Su, who’s a great CEO in her own right. Intel Corp (NASDAQ:INTC)—we’re watching. We’ve seen this surge here. It might take a rest for a little while because I don’t think the numbers are there near term. But with the backing of the US government, which I think was a really nice move by the Trump administration, you can’t count them out. You can’t count them out, but they really don’t have an AI strategy that’s as visible as the others that we recommend.”
Ben Reitzes said he’s recommending Nvidia, Broadcom and AMD.
6. Freeport-McMoRan Inc (NYSE:FCX)
Number of Hedge Fund Investors: 96
Steven Grasso, the CEO of Grasso Global, said in a recent program on CNBC that he likes Freeport-McMoRan.
“I’m going to finish where we started. I’m going to go with Freeport-McMoRan Inc (NYSE:FCX). We talked about copper. I’m long it—I’m staying long. And who knows, maybe Lutnick (US Commerce Secretary) announces something.”
Diamond Hill Large Cap Concentrated Fund stated the following regarding Freeport-McMoRan Inc. (NYSE:FCX) in its Q4 2024 investor letter:
“Among our bottom individual contributors in Q4 were HCA Healthcare and Freeport-McMoRan Inc. (NYSE:FCX). Copper-focused mining company Freeport-McMoRan faced declining copper prices amid a generally challenging macroeconomic environment, including a strong US dollar, ongoing US-China trade tensions, the potential for increased tariffs under President-elect Trump’s administration and general post-election uncertainty.”
5. Citigroup (NYSE:C)
Number of Hedge Fund Investors: 102
Jim Lebenthal, a partner at Cerity Partners, said in a recent program on CNBC that there’s a “lot more opportunity” yet to come for Citigroup (NYSE:C). The analyst talked about the bank’s valuation.
“City has a very specific set of circumstances to it—not necessarily applying to Bank of America or Goldman Sachs—but they’re about to do the Banamex transaction sometime in the next three to four months. Spin that out. After that happens, I see absolutely no reason why this should trade at a discount to tangible book value. It’s just below that right now. I mean, you look at something like Bank of America at 1.9 times tangible book value, and I say rhetorically, why shouldn’t the group be there? If that were to happen, that would be almost a double from here. Now, it’s a little bit provocative. We’ll talk again when we’re at 120% of tangible book value, which would be around 120–125.”
Citigroup shares recently rose after the company posted better-than-expected quarterly results. The company raised its full-year guidance for net interest income amid expectations for continued fee momentum across the Investment Banking, Services and Wealth units.
Hotchkis & Wiley Large Cap Disciplined Value Fund stated the following regarding Citigroup Inc. (NYSE:C) in its second quarter 2025 investor letter:
“Citigroup Inc. (NYSE:C) is one of the largest US banks by total assets. Investment in its IT, compliance and risk capabilities have pressured margins and returns over recent years, obscuring the banks strong core franchise. With these investments now largely complete we expect Citi’s expense to decline and its margins and returns to be more consistent with peers. Citigroup performed well in the quarter on improved profitability and positive operating leverage. We think that C is very undervalued on our normal expectations and would still be attractive even if they do not fully achieve their goals.”
4. Advanced Micro Devices Inc (NASDAQ:AMD)
Number of Hedge Fund Investors: 113
On October 9, Josh Brown from CNBC commented on AMD’s massive surge following its deal with OpenAI. Brown said he fails to understand the “thought process” of buying stocks based on their short-term spikes. Here is what Brown said:
“Who buys charts like this? Who’s the buyer today? I can’t even imagine who that last muppet must be that owns this stock no matter what. I can’t even imagine what the thought process is. It looks incredible, obviously, but does nobody think that there’s the potential for two or three bad days in the market? Half of that 43% could be wiped away. You have multi-hundred billion dollar market cap companies going up 40 and 50% inside of a week. Yeah, it’s ludicrous activity. It doesn’t mean Advanced Micro Devices Inc (NASDAQ:AMD) doesn’t deserve to be there—it’s the speed at which these things are happening.”
AMD shares jumped after the company announced a multi-year agreement with OpenAI to provide AI chips to the ChatGPT maker.
Macquarie Core Equity Fund stated the following regarding Advanced Micro Devices, Inc. (NASDAQ:AMD) in its second quarter 2025 investor letter:
“Advanced Micro Devices, Inc. (NASDAQ:AMD) designs and manufactures semiconductors, including central processing units (CPUs), graphics processing units (GPUs), and other high-performance computing solutions for various markets like gaming, data centers, and AI. The company currently maintains a small market share for GPUs used for AI applications though by 2027, we believe the company will have product on par with the market leader, NVIDIA. Hyperscale customers with deep programming expertise may increasingly decide to dual-source high-end chips leading to much larger revenue and profit gains in coming years for AMD than investors currently expect.”